About CURE's SUDEP Program
Sudden Unexpected Death in Epilepsy (SUDEP), which occurs when a seemingly healthy person with epilepsy dies for no known obvious reason, is perhaps the most devastating possible consequence of epilepsy. SUDEP can happen to anyone with epilepsy, although certain individuals are at a greater risk. While certain steps can be taken to reduce this risk, there is a critical need for continued SUDEP research to understand the underlying mechanisms in order to prevent SUDEP.
In response to bereaved families looking for answers, CURE, in 2004, launched the first ever private US research program dedicated to advancing understanding of SUDEP and its prevention. Since this time, CURE has supported over 40 investigators who have dramatically changed our understanding of this phenomenon. Simultaneously, CURE, in partnership with families, other non-profits and governmental agencies, have created a strong movement driving research, awareness, advocacy and increased funding to tackle this problem. CURE remains committed to unraveling the mysteries of SUDEP. We will continue to work closely with families and the research community to identify pressing needs while pushing for innovative solutions that ultimately lead to SUDEP prevention.
CURE has been a leader in SUDEP by:
- Awarding more than $3.8 million in SUDEP grants to date, supporting over 30 research projects.
- Collaborating with more than 40 SUDEP investigators
- Increasing federal funding for SUDEP research
- Actively engaging with the North American SUDEP Registry and the Sudden Death in the Young Registry, and supporting development of the Canadian SUDEP Registry through the Canadian Paediatric Surveillance Program; these organizations collect information, DNA, brain and/or other tissues from people with epilepsy who have died unexpectedly to understand the cause of death, conduct scientific studies about the causes of SUDEP, and develop preventative measures.
- Elevating physician and patient awareness about SUDEP
- Helping pass SUDEP reporting legislation in select states
- Helping to establish respiratory arrest as a leading cause of SUDEP
- Revealing the link between SUDEP and genes found in both the brain and heart
- Helping to establish generalized tonic-clonic seizures as a clear risk factor
- Supporting the 2017 American Academy of Neurology SUDEP Practice Guidelines for physicians.
- SUDEP refers to the sudden, unexpected, witnessed or unwitnessed, non-traumatic and non-drowning death in patients with epilepsy. It may be seen with or without evidence of a recent seizure and with no cause of death found on autopsy (Nashef et al., Epilepsia, 1997)
- SUDEP is rare in individuals with well-controlled epilepsy, but relatively common in individuals with drug-resistant epilepsy (DiGiorgio et al., Frontiers in Neurology, 2017)
- The greatest risk factor for SUDEP is a history of frequent generalized tonic-clonic seizures (DiGiorgio et al., Frontiers in Neurology, 2017)
- Ensuring that epilepsy is well-controlled with a combination of medication, diet, and/or other therapeutic mechanism is essential to decreasing the risk of SUDEP.
If you are a patient, friend, or family member affected by SUDEP who is looking to get more involved in SUDEP research or the SUDEP community, attend a PAME meeting. These events provide a forum for people with epilepsy and their families to interact with each other, clinicians and researchers, and to pay tribute to loved ones who died of SUDEP.
In addition to attending a PAME meeting, you can get involved by donating to HOPE4SUDEP. This initiative honors the life of Cameron Benninghoven, who passed away in 2009 from SUDEP. Cameron’s family and friends have partnered with CURE to maximize their fundraising and awareness efforts. Donations to HOPE4SUDEP will be used for SUDEP and epilepsy research to investigate causes and prevention of seizures.